- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03936764
Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery (Preo-Dens)
Pulmonary resection surgery is currently the recommended curative treatment for early stages of non-small cell lung cancer. The implementation of preoperative respiratory rehabilitation programs has shown beneficial results on pulmonary function, functional level, cardiorespiratory conditioning and the occurrence and severity of postoperative complications in this population of patients. Despite these benefits, the most recent meta-analyzes highlight the fact that training modalities (duration, frequencies, intensity) are very heterogeneous. It is then difficult to structure a program only on the basis of data from the literature.
In a cohort analysis of 50 patients trained from 2014 to 2017, our team reported a significantly greater improvement in physiological parameters in patients who performed 15 or more preoperative training sessions. This number of 15 outpatient sessions is therefore considered a minimum training goal in our current practice.
The difficulty of the oncological context is to find the compromise between the necessary diligence to initiate the cancer surgical treatment and the necessary time to obtain the benefits of the preoperative rehabilitation. Previous study reports the difficulty of setting up a four-week training program, perceived as delaying surgery. In order to prevent any risk of prolonging the surgical management time, rehabilitation teams routinely offer short programs with high training frequencies of up to five to six sessions per week. It seems important to note that preoperative rehabilitation is normally considered in patients for whom there is a risk of moderate to high postoperative complications according to the European and North American recommendations. Thus these patients generally benefit from a longer period of assessment than patients whose risk is considered low in terms of their cardio-respiratory and muscular function.
The median duration between the physiological evaluation of patients considered "at risk" before pulmonary resection surgery is 44 (Q1-Q3 29-76) days at Rouen University Hospital, with no significant differences observed between patients who have benefited or not from preoperative rehabilitation. Some teams have even pointed out that there is no difference in survival prognosis in the short or long term between patients who have had an operative delay of more or less 60 or 90 days respectively, which shows the compatibility with the set up a dedicated training course.
As mentioned earlier, the concept of delay has led to extremely dense training for a functionally and cardio-respiratory fragile target population as evidenced by pejorative VO2peak. The density of the training, failing to generate significant physiological stimulation, may increase fatigue or limit adherence to training, especially if it requires movement, and is added to a therapeutic planning including many consultations and further examinations. To date, no study has evaluated the density of preoperative supervised training on pre-surgical benefits.
The objective of this work is to compare the effectiveness of a program of 15 training sessions on VO2peak according to two different densities, namely five times a week over three weeks, or three times a week over five weeks.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Normandie
-
Bois-Guillaume, Normandie, Ranska, 76230
- ADIR Association
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Age> 18 years old;
- Beneficiary of a social security scheme;
- Non-Small Cell Lung Cancer or suspicion of bronchial neoplasia;
- Addressed to respiratory rehabilitation in a preoperative setting with a moderate to high risk estimate (VO2peak < 20 ml/kg/min);
- Intervention date not established when included in the program or ≥ 5 wk.
Exclusion Criteria:
- Patient under guardianship;
- Pregnant or lactating woman;
- Cardiological contraindication to training;
- Neoadjuvant radio-chemotherapy;
- Refusal to carry out a training program in a rehabilitation center;
- Orthopedic, neurological, vascular or neuromuscular pathology limiting training;
- Exacerbation or deterioration of the general condition requiring stopping the preoperative re-training program;
- Modification of the therapeutic project at a multidisciplinary consultation meeting requiring the cessation of rehabilitation or participation in the study.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Muut: Group 1
5 Preoperative Pulmonary Rehabilitation sessions / week during 3 weeks.
|
Each prehabilitation session will last approximately 90 minutes and will include:
|
|
Muut: Group 2
3 Preoperative Pulmonary Rehabilitation sessions / week during 5 weeks.
|
Each prehabilitation session will last approximately 90 minutes and will include:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
peak dioxyen consumption (VO2peak)
Aikaikkuna: before the preoperative training program
|
VO2peak (in ml/kg/min) measured during and incremental Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
peak dioxyen consumption (VO2peak)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
VO2peak (in ml/kg/min) measured during and incremental Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
peak work-rate (WRpeak)
Aikaikkuna: before the preoperative training program
|
maximum power reached during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
peak work-rate (WRpeak)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
maximum power reached during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
oxygen consumption at ventilatory threshold (VO2vt)
Aikaikkuna: before the preoperative training program
|
oxygen consumption at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
oxygen consumption at ventilatory threshold (VO2vt)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
oxygen consumption at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
work-rate at ventilatory threshold (WRvt)
Aikaikkuna: before the preoperative training program
|
work-rate at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
work-rate at ventilatory threshold (WRvt)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
work-rate at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
ventilatory efficiency (VE/VCO2 slope)
Aikaikkuna: before the preoperative training program
|
linear regression of the ratio between the increase in minute ventilation and the expired carbon dioxide flow (VE/VCO2 slope)
|
before the preoperative training program
|
|
ventilatory efficiency (VE/VCO2 slope)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
linear regression of the ratio between the increase in minute ventilation and the expired carbon dioxide flow (VE/VCO2 slope)
|
through preoperative training program completion (15 sessions)
|
|
body mass index (BMI)
Aikaikkuna: before the preoperative training program
|
weight in kilograms divided by the square of height in meters
|
before the preoperative training program
|
|
body mass index (BMI)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
weight in kilograms divided by the square of height in meters
|
through preoperative training program completion (15 sessions)
|
|
fat-free mass
Aikaikkuna: before the preoperative training program
|
impedancemetry (Bodystat® 1500MDD, (5/50 kHz), Bodystat, Douglas, Isle of Man, UK).
|
before the preoperative training program
|
|
fat-free mass
Aikaikkuna: through preoperative training program completion (15 sessions)
|
impedancemetry (Bodystat® 1500MDD, (5/50 kHz), Bodystat, Douglas, Isle of Man, UK).
|
through preoperative training program completion (15 sessions)
|
|
quadriceps peak torque
Aikaikkuna: before the preoperative training program
|
quadriceps peak torque (in Nm) assessed by dynamometry (MicroFET2®, Hogan Health Industries, Inc., UT)
|
before the preoperative training program
|
|
quadriceps peak torque
Aikaikkuna: through preoperative training program completion (15 sessions)
|
quadriceps peak torque (in Nm) assessed by dynamometry (MicroFET2®, Hogan Health Industries, Inc., UT)
|
through preoperative training program completion (15 sessions)
|
|
maximum inspiratory pressure (MIP)
Aikaikkuna: before the preoperative training program
|
Maximum negative oral pressure generated by the patient during inspiration (in cmH2O)
|
before the preoperative training program
|
|
maximum inspiratory pressure (MIP)
Aikaikkuna: through preoperative training program completion (15 sessions)
|
Maximum negative oral pressure generated by the patient during inspiration (in cmH2O)
|
through preoperative training program completion (15 sessions)
|
|
Health related quality of life (HRQoL) questionnaire
Aikaikkuna: before the preoperative training program
|
Full name of the scale : "European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and modular supplement for Lung Cancer patients" (EORTC QLQ-C30 / LC13) The EORTC QLQ-C30, is a 30 questions questionnaire developed by the European Organization for Research and Treatment of Cancer, to assess the QoL of cancer patients. It has been translated and validated into over 100 languages and is used in more than 3,000 studies worldwide. For patients with Lung Cancer, a 13 questions modular supplement, the LC-13, is validated. The HRQoL is therefore evaluated by a set of 43 questions gathering all aspects that could be impacted. A raw score is calculated for each dimension and summary score, then standardized from 0 to 100 points. The additional module for Lung Cancer (LC-13) provides a complementary dimension with specific items related to the tumor site. (see Fayers et. al., The EORTC QLQ-C30 Scoring Manual (3rd Edition) 2001. |
before the preoperative training program
|
|
Health related quality of life (HRQoL) questionnaire
Aikaikkuna: through preoperative training program completion (15 sessions)
|
Full name of the scale : "European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and modular supplement for Lung Cancer patients" (EORTC QLQ-C30 / LC13) The EORTC QLQ-C30, is a 30 questions questionnaire developed by the European Organization for Research and Treatment of Cancer, to assess the QoL of cancer patients. It has been translated and validated into over 100 languages and is used in more than 3,000 studies worldwide. For patients with Lung Cancer, a 13 questions modular supplement, the LC-13, is validated. The HRQoL is therefore evaluated by a set of 43 questions gathering all aspects that could be impacted. A raw score is calculated for each dimension and summary score, then standardized from 0 to 100 points. The additional module for Lung Cancer (LC-13) provides a complementary dimension with specific items related to the tumor site. (see Fayers et. al., The EORTC QLQ-C30 Scoring Manual (3rd Edition) 2001. |
through preoperative training program completion (15 sessions)
|
|
Adherence to sessions
Aikaikkuna: through preoperative training program completion (15 sessions)
|
number of sessions performed on number of sessions planned
|
through preoperative training program completion (15 sessions)
|
|
Postoperative Complications
Aikaikkuna: At 30 days post-intervention
|
number and type of complication during the 30 days post lung resection.
Each complication severity is evaluated with the Clavien-Dindo scale.
|
At 30 days post-intervention
|
Yhteistyökumppanit ja tutkijat
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- Preo-Dens
- ID-RCB : 2018-A03301-54 (Rekisterin tunniste: 2018-A03301-54)
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Ei-pienisoluinen keuhkosyöpä
-
Everest Medicines (Beijing) Co., Ltd.Ei vielä rekrytointiaSquamous Non-Small Cell Lung Cancer sqNSCLC
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Aktiivinen, ei rekrytointiMetastaattinen keuhkojen ei-pienisolusyöpä | Tulenkestävä keuhkojen ei-pienisolusyöpä | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8Yhdysvallat
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Aktiivinen, ei rekrytointiStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | Keuhkojen ei-pienisolukarsinooma | Vaiheen III keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8 | Vaiheen II keuhkosyöpä AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Vaiheen IIB keuhkosyöpä AJCC v8 | Vaiheen IIIA keuhkosyöpä AJCC v8 | Vaiheen IIIB... ja muut ehdotYhdysvallat
-
Stanford UniversityRekrytointiStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8 | Keuhkokarsinooma | Metastaattinen pahanlaatuinen kasvain keuhkoissaYhdysvallat
-
National Cancer Institute (NCI)NRG OncologyLopetettuStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8 | Keuhkojen ei-squamous ei-pienisolusyöpäYhdysvallat
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)LopetettuPienisoluinen keuhkosyöpä | Stage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8Yhdysvallat
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Aktiivinen, ei rekrytointiMetastaattinen keuhkojen ei-pienisolusyöpä | Stage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | Vaiheen III keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8 | Vaiheen II keuhkosyöpä AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Vaiheen IIB keuhkosyöpä AJCC v8 | Vaiheen IIIA keuhkosyöpä AJCC v8 | Vaiheen... ja muut ehdotYhdysvallat
-
Emory UniversityNational Cancer Institute (NCI)RekrytointiStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | Keuhkojen ei-pienisolukarsinooma | IV vaiheen keuhkosyöpä AJCC v8Yhdysvallat
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); AstraZenecaAktiivinen, ei rekrytointiStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | IV vaiheen keuhkosyöpä AJCC v8 | Laaja vaiheinen keuhkopienisolusyöpäYhdysvallat
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; California Institute... ja muut yhteistyökumppanitAktiivinen, ei rekrytointiStage IVA Lung Cancer AJCC v8 | Vaihe IVB keuhkosyöpä AJCC v8 | Keuhkojen ei-pienisolukarsinooma | IV vaiheen keuhkosyöpä AJCC v8Yhdysvallat
Kliiniset tutkimukset Preoperative Pulmonary Rehabilitation
-
XeltisAktiivinen, ei rekrytointiSydänvika, synnynnäinenYhdysvallat, Bulgaria, Malesia, Puola
-
Amsterdam UMC, location VUmcTrombosestichting NederlandRekrytointi
-
XeltisPeruutettuSydänvika, synnynnäinenUnkari, Malesia, Puola, Slovakia
-
Fundacion Clinica Valle del LiliEi vielä rekrytointiaPostoperatiiviset komplikaatiot | Kuntoutus | Leikkauksen jälkeinen hoito
-
CEU San Pablo UniversityValmis
-
Washington University School of MedicinePeruutettuPerifeeriset keuhkovauriot
-
Atrial Fibrillation NetworkEi vielä rekrytointiaEteisvärinä (AF) | Mitraaliläpän (MV) regurgitaatioSaksa
-
Rostrum Medical Innovations Inc.Medical InitiativesEi vielä rekrytointiaAivohalvaus | Keuhkokuume | COPD | Akuutti keuhkovaurio/akuutti hengitysvaikeusoireyhtymä (ARDS) | Tuulettimet, mekaanisetRanska, Yhdysvallat, Itävalta, Tšekki
-
Umran KaracaValmisEndoskopia, maha-suolikanava | COPD (krooninen obstruktiivinen keuhkosairaus)Turkki (Türkiye)
-
Emory UniversityAtlanta VA Medical CenterValmisSepelvaltimotauti | Sydän-ja verisuonitautiYhdysvallat